Clinical trial
The Effect of Dietary Fructose on Gut Microbiota and Hepatosteatosis in Healthy Men
NCT04898621 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Dietary Fructose on Gut Microbiota and Hepatosteatosis in Healthy Men
- Lead sponsor
- Shanghai Zhongshan Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2021
- Completion date
- December 31, 2022
- Enrollment
- 58 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dietary fructose exposure, hepatic steatosis